SEC 13F Intelligence

Ghost Tree Capital, LLC / VKTX

Ghost Tree Capital, LLC’s Viking Therapeutics Inc Position

Does Ghost Tree Capital, LLC own Viking Therapeutics Inc (VKTX)? Yes — 140.0K shares worth $9M (+2.68% of its 13F portfolio) as of Q3 2024, up from 95.0K shares the prior filed quarter.

Position Value
$9M
Q3 2024
Shares
140.0K
% of Portfolio
+2.68%
Quarters Held
7
currently held

Position History VKTX

Reported value by quarter
Q4 ’22: $3MQ4 ’22Q1 ’23: $10MQ1 ’23Q2 ’23: $11MQ2 ’23Q3 ’23: $2MQ3 ’23Q1 ’24: $6MQ1 ’24Q2 ’24: $5MQ2 ’24Q3 ’24: $9MQ3 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2024140.0K$9M+2.68%
Q2 202495.0K$5M+1.58%
Q1 202473.0K$6M+1.66%
Q3 2023225.0K$2M+0.82%
Q2 2023650.0K$11M+3.48%
Q1 2023600.0K$10M+2.95%
Q4 2022300.0K$3M+1.20%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Ghost Tree Capital, LLC’s full portfolio or all institutional holders of VKTX.